Hot Features
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial design... Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.003 | 8.57142857143 | 0.035 | 0.046 | 0.033 | 1650628 | 0.03947866 | DE |
| 4 | -0.008 | -17.3913043478 | 0.046 | 0.056 | 0.033 | 2986611 | 0.04420069 | DE |
| 12 | 0.014 | 58.3333333333 | 0.024 | 0.071 | 0.019 | 3908291 | 0.04495274 | DE |
| 26 | 0.021 | 123.529411765 | 0.017 | 0.071 | 0.014 | 2505600 | 0.0396032 | DE |
| 52 | 0.016 | 72.7272727273 | 0.022 | 0.071 | 0.014 | 2029687 | 0.03592814 | DE |
| 156 | 0.016 | 72.7272727273 | 0.022 | 0.071 | 0.014 | 2029687 | 0.03592814 | DE |
| 260 | 0.016 | 72.7272727273 | 0.022 | 0.071 | 0.014 | 2029687 | 0.03592814 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.